我要投票 翔宇SUNHOVER在滋补食材药材行业中的票数:144
· 外 推 电 报 ·
2025-04-03 00:11:12 星期四

【翔宇SUNHOVER是哪个国家的品牌?】

翔宇SUNHOVER是什么牌子?「翔宇SUNHOVER」是 翔宇药业股份有限公司 旗下著名品牌。该品牌发源于山东省临沂市,由创始人林董在1999年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力翔宇SUNHOVER品牌出海!通过在本页面挂载翔宇SUNHOVER品牌的产品链接和联系邮箱,可以提高翔宇SUNHOVER产品曝光!跨境电商爆单神器,目前只要100元/年哦~

翔宇药业股份有限公司,山东省著名商标,孕产妇儿童补血知名品牌,高新技术企业,大型现代化民营制药企业


翔宇药业股份有限公司是翔宇集团控股上市公司,下辖一家全资子公司(山东仁和堂药业有限公司)和一家控股公司(山东诺维尔斯医药科技有限公司两家子公司)。拥有中药健康园、仁和堂化药园两大生产基地。生产妇科、儿科、精神、补益、心脑血管等11类制剂及原料药138个品种300多个品规。具有自主知识产权、自主定价权、国家中药保护品种及进入国家医保、基药、新农合目录的药品200多个。

翔宇药业坚持“打造中国妇幼用药一线药企”的企业发展战略,目前已经与3000多个经销商、100000多家医疗药店终端展开合作,销售网络遍布全国,部分产品远销欧美,为越来越多的家庭提供专业、优质的产品和服务!

化药盐酸地芬尼多取得美国DMF注册,盐酸米安色林、乳酸氟罗沙星原料药为国内独家产品替代进口,产品销往日本、墨西哥、美国等多个国家和地区。

翔宇药业严格按照新版GMP的要求设计,实施高标准GMP生产体系和质量体系,执行高于国标的内控标准。近年来,先后投入3.5亿元升级改造生产系统、生态处理系统。新建多功能提取车间及综合固体制剂车间,引进自动化控制系统、国际先进的药品检测设备,确保产品质量的稳定和优良。


英文翻译:Xiangyu Pharmaceutical Co., Ltd., a famous trademark of Shandong Province, a well-known brand of maternal and child blood supplement, a high-tech enterprise, and a large modern private pharmaceutical enterprise, Xiangyu Pharmaceutical Co., Ltd. is a listed company controlled by Xiangyu Group, which has a wholly-owned subsidiary (Shandong Renhetang Pharmaceutical Co., Ltd.) and a holding company (Shandong novels Pharmaceutical Technology Co., Ltd.) Subsidiaries). There are two production bases of Chinese medicine health park and Renhetang pharmaceutical park. More than 300 specifications of 138 varieties of 11 kinds of preparations and APIs, including Gynecology, pediatrics, spirit, tonic, cardio cerebrovascular and so on, are produced. There are more than 200 drugs with independent intellectual property rights, independent pricing rights, national protected varieties of traditional Chinese medicine and entering the national medical insurance, basic medicine and new rural cooperative medical insurance catalogue. Xiangyu pharmaceutical adheres to the enterprise development strategy of "building a first-line pharmaceutical enterprise of Chinese maternal and child medicine". At present, it has cooperated with more than 3000 distributors and 100000 Medical Pharmacy terminals. Its sales network spreads all over the country, and some products are exported to Europe and America, providing more and more families with professional and high-quality products and services! Difenidol hydrochloride, a chemical drug, has been registered with DMF in the United States. The raw materials of mianserin hydrochloride and fleroxacin lactate are the exclusive products in China, which are sold to Japan, Mexico, the United States and other countries and regions. Xiangyu pharmaceutical has designed in strict accordance with the requirements of the new GMP, implemented a high standard GMP production system and quality system, and implemented internal control standards higher than the national standard. In recent years, 350 million yuan has been invested in upgrading production system and ecological treatment system. New multi-functional extraction workshop and comprehensive solid preparation workshop, introduction of automatic control system, international advanced drug testing equipment, to ensure the stability and excellence of product quality.

本文链接: https://www.waitui.com/brand/c76e2d7a6.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

ST永悦:公司股票申请撤销其他风险警示

36氪获悉,ST永悦公告,根据有关规定,公司触及的其他风险警示情形已消除,且不存在触及退市风险警示和其他风险警示的情形,公司已向上海证券交易所提出撤销相应的其他风险警示申请。上海证券交易所将按照《股票上市规则》的相关规定,根据实际情况,决定是否撤销对公司股票实施的其他风险警示。在上海证券交易所审核期间,公司股票不停牌,仍正常交易。最终申请撤销情况以上海证券交易所审核意见为准。

12分钟前

热门中概股美股盘前涨跌不一,蔚来跌超1%

36氪获悉,热门中概股美股盘前涨跌不一,截至发稿,蔚来、网易跌超1%,京东跌0.24%,理想汽车跌0.16%,阿里巴巴跌0.06%;小鹏汽车张超1%,爱奇艺涨0.45%,百度涨0.2%。

12分钟前

腾讯会议称服务已经恢复

36氪获悉,腾讯会议官博发文表示,服务已经全面恢复,可以正常使用。

12分钟前

必和必拓曾考虑剥离澳大利亚铁矿石和煤炭业务

知情人士称,必和必拓集团2023年和2024年准备竞购英美资源集团时,曾考虑剥离其澳大利亚铁矿石和煤炭业务。必和必拓选择暂且不推进该计划。(新浪财经)

12分钟前

贵州茅台:2024年营业收入1708.99亿元,同比增长15.71%

36氪获悉,贵州茅台发布2024年业绩报告。报告显示,2024年营业收入1708.99亿元,同比增长15.71%;归属于上市公司股东的净利润862.28亿元,同比增长15.38%;拟向全体股东每10股派发现金红利276.24元(含税)。

12分钟前

本页详细列出关于优联UNION的品牌信息,含品牌所属公司介绍,优联UNION所处行业的品牌地位及优势。
咨询